Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sonnet BioTherapeutics Holdings (SONN)
NASDAQ:SONN
RESEARCH TOOLSreports
Sonnet BioTherapeutics Holdings (SONN) Ownership - Who Owns Sonnet BioTherapeutics Holdings?
406 Followers
Sonnet BioTherapeutics Holdings (SONN) Ownership Overview
33.70% Insiders
0.73% Mutual Funds
0.48% Other Institutional Investors
65.10% Public Companies and
Individual Investors
The ownership structure of Sonnet BioTherapeutics Holdings (SONN) stock is a mix of institutional, retail and individual investors. Approximately 1.21% of the company’s stock is owned by Institutional Investors, 33.70% is owned by Insiders and 65.10% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 15, 2023 | Susan Dexter Cto | Bought | $7000 |
| May 31, 2023 | Albert D. Dyrness Director | Bought | $10697 |
| May 18, 2023 | Nailesh Bhatt Director | Bought | $5750 |
| May 15, 2023 | Pankaj Mohan Cob, Pres & Ceo,director | Bought | $81752 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 38,637 | Insider | 1.26% | 70,319 | |
| 26,971 | Insider | 0.88% | 49,087 | |
| 18,100 | Insider | 0.59% | 32,942 | |
| 17,246 | Insider | 0.56% | 31,388 | |
| 16,500 | Insider | 0.54% | 30,030 | |
| 14,726 | Institution | 0.48% | 26,801 | |
| 14,726 | Institution | 0.48% | 26,801 | |
| 14,663 | Insider | 0.48% | 26,687 | |
| 7,652 | Institution | 0.25% | 13,927 | |
| 811 | Insider | 0.03% | 1,476 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 14,726 | Institution | 0.48% | 26,801 | |
| 7,652 | Institution | 0.25% | 13,927 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 14,726 | Institution | 0.48% | 27,390 |
FAQ
Who Owns Sonnet BioTherapeutics Holdings (SONN)?
According to the latest TipRanks data, approximately 0.48% of the company's stock is held by institutional investors, 33.70% is held by insiders, and 65.10% is held by retail investors.
What percentage of Sonnet BioTherapeutics Holdings (SONN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.48% of Sonnet BioTherapeutics Holdings (SONN) stock is held by institutional investors.
What percentage of Sonnet BioTherapeutics Holdings (SONN) stock is held by retail investors?
According to the latest TipRanks data, approximately 65.10% of Sonnet BioTherapeutics Holdings (SONN) stock is held by retail investors.
Who owns the most shares of Sonnet BioTherapeutics Holdings (SONN)?
Keith J. Johnson owns the most shares of Sonnet BioTherapeutics Holdings (SONN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.